BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fujii S, Shinjo K, Matsumoto S, Harada T, Nojima S, Sato S, Usami Y, Toyosawa S, Morii E, Kondo Y, Kikuchi A. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma. Oncotarget 2016;7:81571-87. [PMID: 27835592 DOI: 10.18632/oncotarget.13147] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Xie N, Shu Q, Wang Z, Huang X, Wang Y, Qin B, Chen Y, Liu N, Dong L, Wu J, Song Y. ARL11 correlates with the immunosuppression and poor prognosis in breast cancer: A comprehensive bioinformatics analysis of ARL family members. PLoS ONE 2022;17:e0274757. [DOI: 10.1371/journal.pone.0274757] [Reference Citation Analysis]
2 Imai T, Naruse M, Machida Y, Fujii G, Mutoh M, Ochiai M, Takahashi M, Nakagama H. Feeding a High-Fat Diet for a Limited Duration Increases Cancer Incidence in a Breast Cancer Model. Nutr Cancer 2022;:1-13. [PMID: 36263881 DOI: 10.1080/01635581.2022.2132267] [Reference Citation Analysis]
3 Fujii S, Fujimoto T, Hasegawa K, Nagano R, Ishibashi T, Kurppa KJ, Mikami Y, Kokura M, Tajiri Y, Kibe T, Wada H, Wada N, Kishida S, Higuchi Y, Kiyoshima T. The Semaphorin 3A-AKT axis-mediated cell proliferation in salivary gland morphogenesis and adenoid cystic carcinoma pathogenesis. Pathol Res Pract 2022;236:153991. [PMID: 35759940 DOI: 10.1016/j.prp.2022.153991] [Reference Citation Analysis]
4 Hasegawa K, Fujii S, Kurppa KJ, Maehara T, Oobu K, Nakamura S, Kiyoshima T. Clear Cell Squamous Cell Carcinoma of the Tongue Exhibits Characteristics as an Undifferentiated Squamous Cell Carcinoma. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fujii S, Ishibashi T, Kokura M, Fujimoto T, Matsumoto S, Shidara S, Kurppa KJ, Pape J, Caton J, Morgan PR, Heikinheimo K, Kikuchi A, Jimi E, Kiyoshima T. RAF1-MEK/ERK pathway-dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation. J Pathol 2021. [PMID: 34622442 DOI: 10.1002/path.5814] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
6 Harada A, Matsumoto S, Yasumizu Y, Shojima K, Akama T, Eguchi H, Kikuchi A. Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion. Elife 2021;10:e66721. [PMID: 34590580 DOI: 10.7554/eLife.66721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Xie N, Bai Y, Qiao L, Bai Y, Wu J, Li Y, Jiang M, Xu B, Ni Z, Yuan T, Shi Y, Wu K, Xu F, Wang J, Dong L, Liu N. ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments. J Cell Mol Med 2021;25:4014-27. [PMID: 33724652 DOI: 10.1111/jcmm.16366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Harada A, Matsumoto S, Yasumizu Y, Akama T, Eguchi H, Kikuchi A. Recruitment of KRAS downstream target ARL4C to membrane protrusions accelerates pancreatic cancer cell invasion.. [DOI: 10.1101/2021.02.23.432112] [Reference Citation Analysis]
9 Chen Q, Fu WJ, Tang XP, Wang L, Niu Q, Wang S, Lin Y, Cao MF, Hu R, Wen HY, Wang Y, Zhang X, Yao XH. ADP-Ribosylation Factor Like GTPase 4C (ARL4C) augments stem-like traits of glioblastoma cells by upregulating ALDH1A3. J Cancer 2021;12:818-26. [PMID: 33403039 DOI: 10.7150/jca.45052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hasegawa K, Fujii S, Matsumoto S, Tajiri Y, Kikuchi A, Kiyoshima T. YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation. J Pathol 2021;253:80-93. [PMID: 32985688 DOI: 10.1002/path.5553] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 21.0] [Reference Citation Analysis]
11 Cai J, Xu Y, Zhang W, Ding S, Sun Y, Lyu J, Duan M, Liu S, Huang L, Zhou F. A comprehensive comparison of residue-level methylation levels with the regression-based gene-level methylation estimations by ReGear. Brief Bioinform 2021;22:bbaa253. [PMID: 33048108 DOI: 10.1093/bib/bbaa253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Romero-Garcia S, Prado-Garcia H, Carlos-Reyes A. Role of DNA Methylation in the Resistance to Therapy in Solid Tumors. Front Oncol 2020;10:1152. [PMID: 32850327 DOI: 10.3389/fonc.2020.01152] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 18.5] [Reference Citation Analysis]
13 Zhong JY, Cui RR, Lin X, Xu F, Zhu T, Li F, Wu F, Zhou E, Yi L, Yuan LQ. Aberrant DNA methylation of synaptophysin is involved in adrenal cortisol-producing adenoma. Aging (Albany NY) 2019;11:5232-45. [PMID: 31352437 DOI: 10.18632/aging.102119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Casalou C, Ferreira A, Barral DC. The Role of ARF Family Proteins and Their Regulators and Effectors in Cancer Progression: A Therapeutic Perspective. Front Cell Dev Biol 2020;8:217. [PMID: 32426352 DOI: 10.3389/fcell.2020.00217] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
15 Sun Y, Zhang Z, Xiang F, Zhang M, Chen Q, Tang L, Zhu L, Liu J, Meng Z, Hu J, Luo X, Ni Z, Wang X. Decreasing Arl4c expression by inhibition of AKT signal in human lung adenocarcinoma cells. Life Sciences 2020;246:117428. [DOI: 10.1016/j.lfs.2020.117428] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Kimura K, Matsumoto S, Harada T, Morii E, Nagatomo I, Shintani Y, Kikuchi A. ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target. Cancer Sci 2020;111:951-61. [PMID: 31925985 DOI: 10.1111/cas.14303] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
17 Fujii S, Tajiri Y, Hasegawa K, Matsumoto S, Yoshimoto RU, Wada H, Kishida S, Kido MA, Yoshikawa H, Ozeki S, Kiyoshima T. The TRPV4-AKT axis promotes oral squamous cell carcinoma cell proliferation via CaMKII activation. Lab Invest 2020;100:311-23. [PMID: 31857698 DOI: 10.1038/s41374-019-0357-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
18 Sada R, Kimura H, Fukata Y, Fukata M, Yamamoto H, Kikuchi A. Dynamic palmitoylation controls the microdomain localization of the DKK1 receptors CKAP4 and LRP6. Sci Signal 2019;12:eaat9519. [PMID: 31744930 DOI: 10.1126/scisignal.aat9519] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
19 Fujii S, Nagata K, Matsumoto S, Kohashi KI, Kikuchi A, Oda Y, Kiyoshima T, Wada N. Wnt/β-catenin signaling, which is activated in odontomas, reduces Sema3A expression to regulate odontogenic epithelial cell proliferation and tooth germ development. Sci Rep 2019;9:4257. [PMID: 30862786 DOI: 10.1038/s41598-019-39686-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
20 Gonzalez-fierro A, Dueñas-gonzález A. Emerging DNA methylation inhibitors for cancer therapy: challenges and prospects. Expert Review of Precision Medicine and Drug Development 2018;4:27-35. [DOI: 10.1080/23808993.2019.1571906] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 Su KY, Li MC, Lee NW, Ho BC, Cheng CL, Chuang YC, Yu SL, Guo YL. Perinatal polychlorinated biphenyls and polychlorinated dibenzofurans exposure are associated with DNA methylation changes lasting to early adulthood: Findings from Yucheng second generation. Environ Res 2019;170:481-6. [PMID: 30640082 DOI: 10.1016/j.envres.2019.01.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
22 Cacabelos R. Pathoepigenetics: The Role of Epigenetic Biomarkers in Disease Pathogenesis. Pharmacoepigenetics. Elsevier; 2019. pp. 139-89. [DOI: 10.1016/b978-0-12-813939-4.00005-x] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Chen Q, Weng HY, Tang XP, Lin Y, Yuan Y, Li Q, Tang Z, Wu HB, Yang S, Li Y, Zhao XL, Fu WJ, Niu Q, Feng H, Zhang X, Wang Y, Bian XW, Yao XH. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma. J Pathol 2019;247:266-78. [PMID: 30357833 DOI: 10.1002/path.5189] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
24 Wu S, Wu D, Pan Y, Liu H, Shao Z, Wang M. Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis. Pathol Res Pract 2019;215:292-301. [PMID: 30527357 DOI: 10.1016/j.prp.2018.11.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
25 Mikami Y, Fujii S, Kohashi KI, Yamada Y, Moriyama M, Kawano S, Nakamura S, Oda Y, Kiyoshima T. Low-grade myofibroblastic sarcoma arising in the tip of the tongue with intravascular invasion: A case report. Oncol Lett 2018;16:3889-94. [PMID: 30128003 DOI: 10.3892/ol.2018.9115] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
26 Wang S, Wu W. DNA Methylation Alterations in Human Cancers. Epigenetics in Human Disease. Elsevier; 2018. pp. 109-39. [DOI: 10.1016/b978-0-12-812215-0.00005-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Mikami Y, Fujii S, Nagata K, Wada H, Hasegawa K, Abe M, Yoshimoto RU, Kawano S, Nakamura S, Kiyoshima T. GLI-mediated Keratin 17 expression promotes tumor cell growth through the anti-apoptotic function in oral squamous cell carcinomas. J Cancer Res Clin Oncol 2017;143:1381-93. [PMID: 28342001 DOI: 10.1007/s00432-017-2398-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
28 Guo H, Zhang B, Nairn AV, Nagy T, Moremen KW, Buckhaults P, Pierce M. O-Linked N-Acetylglucosamine (O-GlcNAc) Expression Levels Epigenetically Regulate Colon Cancer Tumorigenesis by Affecting the Cancer Stem Cell Compartment via Modulating Expression of Transcriptional Factor MYBL1. J Biol Chem. 2017;292:4123-4137. [PMID: 28096468 DOI: 10.1074/jbc.m116.763201] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
29 Little D. Who or what controls tendon? J Orthop Res 2017;35:944-6. [PMID: 28012199 DOI: 10.1002/jor.23508] [Reference Citation Analysis]
30 Matsumoto S, Fujii S, Kikuchi A. Arl4c is a key regulator of tubulogenesis and tumourigenesis as a target gene of Wnt-β-catenin and growth factor-Ras signalling. J Biochem 2017;161:27-35. [PMID: 28053143 DOI: 10.1093/jb/mvw069] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]